Q3 2025 Holdings
Filed 2025-11-14 | 25 holdings | $703.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| CVS Health Corp(CVS) | COM | 126650100 | $60.2M | 797,900 | 8.6% |
| Dexcom Inc(DXCM) | COM | 252131107 | $57.2M | 850,000 | 8.1% |
| Abbvie Inc(ABBV) | COM | 00287Y109 | $46.4M | 200,326 | 6.6% |
| Medtronic PLC(MDT) | SHS | G5960L103 | $43.2M | 453,347 | 6.1% |
| Charles RIV Labs Intl Inc(CRL) | COM | 159864107 | $41.9M | 268,000 | 6.0% |
| ELI Lilly & Co(LLY) | COM | 532457108 | $37.8M | 49,555 | 5.4% |
| Brightspring Health Svcs Inc(BTSG) | COM | 10950A106 | $36.6M | 1,238,520 | 5.2% |
| Repligen Corp(RGEN) | COM | 759916109 | $36.1M | 270,000 | 5.1% |
| Glaukos Corp(GKOS) | COM | 377322102 | $28.0M | 342,804 | 4.0% |
| Tenet Healthcare Corp(THC) | COM NEW | 88033G407 | $27.9M | 137,448 | 4.0% |
| Exact Sciences Corp(EXAS) | COM | 30063P105 | $27.4M | 500,000 | 3.9% |
| Adaptive Biotechnologies COR(ADPT) | COM | 00650F109 | $27.2M | 1,820,915 | 3.9% |
| Madrigal Pharmaceuticals Inc(MDGL) | COM | 558868105 | $26.8M | 58,378 | 3.8% |
| Guardant Health Inc(GH) | COM | 40131M109 | $25.0M | 400,000 | 3.6% |
| Brookdale SR Living Inc(BKD) | COM | 112463104 | $24.0M | 2,838,361 | 3.4% |
| Cardinal Health Inc(CAH) | COM | 14149Y108 | $21.7M | 138,011 | 3.1% |
| Jazz Pharmaceuticals PLC(JAZZ) | SHS USD | G50871105 | $19.8M | 150,000 | 2.8% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $18.4M | 131,390 | 2.6% |
| West Pharmaceutical Svsc Inc(WST) | COM | 955306105 | $18.4M | 70,000 | 2.6% |
| Adapthealth Corp(AHCO) | COMMON STOCK | 00653Q102 | $17.2M | 1,924,132 | 2.4% |
| Veracyte Inc(VCYT) | COM | 92337F107 | $16.7M | 485,000 | 2.4% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $15.5M | 1,971,260 | 2.2% |
| Doximity Inc(DOCS) | CL A | 26622P107 | $15.4M | 210,000 | 2.2% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $7.3M | 270,000 | 1.0% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $7.3M | 9,900 | 1.0% |